ScholarWorks@Korea University: Hong, Sung hoi

Detailed Information

Hong, Sung hoi (홍성회)

College of Health Sciences (School of Biosystems and Biomedical Sciences)

Research Area

Tel 02-3290-5636
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

UbcH6:3||exosome:3||ataxin1:3||deep learning:2||Induced neural stem cells:2||Induced pluripotent stem cells:2||Ataxin1:2||Huntington's disease:2||Small molecules:2||liquid biopsy:2||tissue inhibitor of metalloproteinase (TIMP):1||transplantation therapy:1||iCSCs:1||293FT:1||Skin damages:1||BCRABL:1||Neural stem cell:1||Protein degradation:1||Protein aggregation:1||Personalized drugs:1||Nonviral transfection:1||Activation:1||Aggregates:1||SUMO1:1||ubiquitination:1||GCC2:1||biomarkers:1||TIMPs:1||tumor treating fields:1||lung cancer:1||surface enhanced Raman spectroscopy:1||Stem cellbased therapies:1||Huntington's diseases:1||stem cell therapy:1||Intrathecal transplantation:1||Hair growth:1||Transfection:1||Spinocerebellar ataxia type I (SCA1):1||Aphakia (ak) mouse:1||Genome analysis:1||Super paramagnetic nanoparticles:1||SCA1:1||Influenza virus:1||cell cycle:1||prediction:1||teratoma:1||CXCL12:1||AKT:1||Human cell model:1||Medium spiny neuron:1||Pharmacogenomics:1||Polyglutamine:1||multiplex RTPCR:1||prohibitin:1||E2F1:1||exosomes:1||early detection:1||cell culture:1||radiotherapy:1||melanin:1||conditioned medium (CM):1||Reprogramming:1||Reprogramming technology:1||MITF:1||Parkinson's disease (PD):1||6hydroxydopamine (6OHDA):1||Embryonic stem cells:1||Repression:1||cellular dysfunction:1||polyglutamine:1||Cell division:1||DNA damage:1||stem cells:1||surfaceenhanced Raman spectroscopy (SERS):1||BMMSC:1||ERK:1||ELK1:1||protein:1||Quantitative and controllable injection:1||Neuropathic pain:1||Transforming growth factorbeta (TGFbeta):1||Single cell:1||Mutant ataxin1:1||aggregates:1||protein interaction:1||transcriptional regulation:1||p16:1||cancer:1||cell morphology:1||lung cancer diagnosis:1||DNA breaks:1||depigmentation:1||direct conversion:1||astrocytes:1||cell conversion:1||DNA doublestrand breaks:1||Neural stem cellconditioned medium:1||Melanin:1||Tyrosinase:1||Tyrosine hydroxylase (TH):1||4dihydroxyphenylalanine (LDOPA):1||Embryonic stem cells (ESCS):1||Thymidine:1||Tumor&#8208:1||STAT3:1||fractionated scheme:1||glioblastoma:1||principal component analysis:1||Chronic myelogenous leukaemia:1||biomarker:1||secreted factors:1||Quantitative:1||Spatiotemporal:1||Genomic stability:1||Cell therapy:1||Dopaminergic neurons:1||CtBP2:1||AXH domain:1||treating fields:1||neural stem cellderived conditioned medium (NSCCM):1||pluripotent stem cells (PSCs):1||CXCR4:1||NSCCM:1||MMPs:1||head and neck cancer:1||Transplantation:1||Gene correction:1||neural stem cells (NSCs):1||a single cell:1||Lineage conversion:1||Spinal cord injury (SCI):1||Spinal GABAergic neurons:1||Neural stem cell extract:1||Hair follicle niche:1||Ubiquitylation:1||Wnt inhibitors:1||L3:1||New DNA sequencing:1||Single nucleotide polymorphisms (SNPs):1||Ecadherin:1||cell therapy:1||RNF2:1||cancer cell:1||nonsmall cell lung cancer:1||convolutional neural networks:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE